BACKGROUND: HIV infection is associated with a wide range of haematological abnormalities. METHODS AND OBJECTIVES: The objectives in this study were to study haematological changes in HIV patients and to correlate them with CD4 cell counts. Two hundred and fifty HIV positive patients referred to the haematology laboratory section for complete haemogram in whom CD4 count was done were included in the study. Haematologic parameters and CD4 counts were studied in each of these patients. Descriptive statistics were applied. Association between two attributes was calculated by chi-square test and p value less than 0.05 was considered statistically significant. RESULTS: Among 250 patients, anaemia was seen in 210 (84%) cases. The most common type was normocytic normochromic (40.4%). Lymphopenia was seen in 163 (65.2%) cases and thrombocytopenia in 45 (18%) cases. The majority of cases (70%) had CD4 cell counts below 200 cells/mm(3). Fifty-four cases (21.6%) had CD4 counts between 200 to 499 cells/mm(3) and 21 (8.4%) cases had CD4 counts more than 500 cells/ mm(3.) In patients with CD4 counts less than 200 cells/mm(3), anaemia was seen in 91.4% cases, leucopenia in 26.8% cases, lymphopenia in 80% cases and thrombocytopenia in 21.7% cases. CONCLUSION: Haematologic manifestations of HIV infection are common and more frequent with progression of disease. The present study revealed a significant increase in the number of cases of anaemia, and lymphopenia, with decreasing CD4 cell counts. Thrombocytopenia is also seen but does not show significant increase with disease progression. The study also highlights the importance of simultaneously treating HIV patients for haematologic manifestations to reduce morbidity.
BACKGROUND:HIV infection is associated with a wide range of haematological abnormalities. METHODS AND OBJECTIVES: The objectives in this study were to study haematological changes in HIVpatients and to correlate them with CD4 cell counts. Two hundred and fifty HIV positive patients referred to the haematology laboratory section for complete haemogram in whom CD4 count was done were included in the study. Haematologic parameters and CD4 counts were studied in each of these patients. Descriptive statistics were applied. Association between two attributes was calculated by chi-square test and p value less than 0.05 was considered statistically significant. RESULTS: Among 250 patients, anaemia was seen in 210 (84%) cases. The most common type was normocytic normochromic (40.4%). Lymphopenia was seen in 163 (65.2%) cases and thrombocytopenia in 45 (18%) cases. The majority of cases (70%) had CD4 cell counts below 200 cells/mm(3). Fifty-four cases (21.6%) had CD4 counts between 200 to 499 cells/mm(3) and 21 (8.4%) cases had CD4 counts more than 500 cells/ mm(3.) In patients with CD4 counts less than 200 cells/mm(3), anaemia was seen in 91.4% cases, leucopenia in 26.8% cases, lymphopenia in 80% cases and thrombocytopenia in 21.7% cases. CONCLUSION: Haematologic manifestations of HIV infection are common and more frequent with progression of disease. The present study revealed a significant increase in the number of cases of anaemia, and lymphopenia, with decreasing CD4 cell counts. Thrombocytopenia is also seen but does not show significant increase with disease progression. The study also highlights the importance of simultaneously treating HIVpatients for haematologic manifestations to reduce morbidity.
Authors: Manisha S Patwardhan; Anit S Golwilkar; Jayant R Abhyankar; Madhavi C Atre Journal: Indian J Pathol Microbiol Date: 2002-04 Impact factor: 0.740
Authors: F Louache; A Bettaieb; A Henri; E Oksenhendler; J P Farcet; P Bierling; M Seligmann; W Vainchenker Journal: Blood Date: 1991-10-01 Impact factor: 22.113
Authors: Robert L Furler; Kevin L Newcombe; Perla M Del Rio Estrada; Gustavo Reyes-Terán; Christel H Uittenbogaart; Douglas F Nixon Journal: AIDS Res Hum Retroviruses Date: 2019-10-07 Impact factor: 2.205
Authors: Jane C Figueiredo; Fred R Hirsch; Lawrence H Kushi; Wendy N Nembhard; James M Crawford; Nicholas Mantis; Laurel Finster; Noah M Merin; Akil Merchant; Karen L Reckamp; Gil Y Melmed; Jonathan Braun; Dermot McGovern; Samir Parekh; Douglas A Corley; Namvar Zohoori; Benjamin C Amick; Ruofei Du; Peter K Gregersen; Betty Diamond; Emanuela Taioli; Carlos Sariol; Ana Espino; Daniela Weiskopf; Alba Gifoni; James Brien; William Hanege; Marc Lipsitch; David A Zidar; Ann Scheck McAlearney; Ania Wajnberg; Joshua LaBaer; E Yvonne Lewis; Raquel A Binder; Ann M Moormann; Catherine Forconi; Sarah Forrester; Jennifer Batista; John Schieffelin; Dongjoo Kim; Giulia Biancon; Jennifer VanOudenhove; Stephanie Halene; Rong Fan; Dan H Barouch; Galit Alter; Swetha Pinninti; Suresh B Boppana; Sunil K Pati; Misty Latting; Andrew H Karaba; John Roback; Rafick Sekaly; Andrew Neish; Ahnalee M Brincks; Douglas A Granger; Amy B Karger; Bharat Thyagarajan; Stefani N Thomas; Sabra L Klein; Andrea L Cox; Todd Lucas; Debra Furr-Holden; Kent Key; Nicole Jones; Jens Wrammerr; Mehul Suthar; Serre Yu Wong; Natalie M Bowman; Viviana Simon; Lynne D Richardson; Russell McBride; Florian Krammer; Meenakshi Rana; Joshua Kennedy; Karl Boehme; Craig Forrest; Steve W Granger; Christopher D Heaney; Maria Knight Lapinski; Shannon Wallet; Ralph S Baric; Luca Schifanella; Marcos Lopez; Soledad Fernández; Eben Kenah; Ashish R Panchal; William J Britt; Iñaki Sanz; Madhav Dhodapkar; Rafi Ahmed; Luther A Bartelt; Alena J Markmann; Jessica T Lin; Robert S Hagan; Matthew C Wolfgang; Jacek Skarbinski Journal: Open Forum Infect Dis Date: 2022-04-27 Impact factor: 4.423
Authors: Guiying Cao; Hai Long; Yuedong Liang; Jue Liu; Xiaoxin Xie; Yanhua Fu; Juan He; Su Song; Siqi Liu; Manna Zhang; Yu Wu; Yaping Wang; Min Du; Wenzhan Jing; Jie Yuan; Min Liu Journal: BMJ Open Date: 2022-07-18 Impact factor: 3.006
Authors: Augustine O Ebonyi; Stephen Oguche; Martha O Ochoga; Oche O Agbaji; Joseph A Anejo-Okopi; Isaac O Abah; Prosper I Okonkwo; John A Idoko Journal: J Virus Erad Date: 2017-10-01